Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy
- 23 December 2020
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 21 (15) , 1688-1698
Abstract
Purpose: The work was performed to investigate the feasibility of preparing ocular inserts loaded with Poly-ε-Caprolactone (PCL) nanoparticles as a sustained ocular delivery system. Methods: First, Atorvastatin Calcium-Poly-ε-Caprolactone (ATC-PCL) nanoparticles were prepared and characterized. Then, the optimized nanoparticles were loaded within inserts formulated with Methylcellulose (MC) and Polyvinyl Alcohol (PVA) by a solvent casting technique and evaluated physically, for in-vitro drug release profile. Finally, an in-vivo study was performed on the selected formulation to prove non-irritability and sustained ocular anti-inflammatory efficacy compared with free drug-loaded ocuserts. Results: The results revealed (ATC-PCL) nanoparticles prepared with 0.5% pluronic F127 were optimized with 181.72±3.6 nm particle size, 0.12±0.02 (PDI) analysis, -27.4± 0.69 mV zeta potential and 62.41%±4.7% entrapment efficiency. Nanoparticles loaded ocuserts manifested compatibility between drug and formulation polymers. Moreover, formulations complied with average weight 0.055±0.002 to 0.143±0.023 mg, and accepted pH. ATC-PCL nanoparticles loaded inserts prepared by 5% MC showed more sustained, prolonged in-vitro release over 24h. In-vivo study emphasized non-irritability, ocular anti-inflammatory effectiveness represented by smaller lid closure scores, and statistically significant lowering in PMN count after 3h. Conclusion: These findings proposed a possibly simple, new and affordable price technique to prepare promising (ATC-PCL) nanoparticles loaded inserts to achieve sustained release with prolonged antiinflammatory efficacy.Keywords
This publication has 29 references indexed in Scilit:
- Controlled release polymeric ocular delivery of acyclovirPharmaceutical Development and Technology, 2010
- Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Nanoparticles made from novel starch derivatives for transdermal drug deliveryJournal of Controlled Release, 2010
- Piroxicam Bioadhesive Ocular Inserts: Physicochemical Characterization and Evaluation in Prostaglandin-Induced InflammationCurrent Eye Research, 2009
- Polymeric nanoparticulate system: A potential approach for ocular drug deliveryJournal of Controlled Release, 2009
- Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: A technical noteAAPS PharmSciTech, 2006
- Preparation and characterization of triclosan nanoparticles for periodontal treatmentInternational Journal of Pharmaceutics, 2005
- Ophthalmic Delivery of Ciprofloxacin Hydrochloride from Different Polymer Formulations: In Vitro and In Vivo StudiesDrug Development and Industrial Pharmacy, 2003
- Ocular Tolerability of Eudragit RS100® and RL100® Nanosuspensions as Carriers for Ophthalmic Controlled Drug DeliveryJournal of Pharmaceutical Sciences, 2002
- PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drugJournal of Controlled Release, 1999